Landon King, M.D., named executive vice dean for the School of Medicine

Dear Colleagues,

I am pleased to announce that Landon S. King, M.D., has agreed to assume additional duties as the School of Medicine’s executive vice dean. Landon is currently the David Marine Professor of Medicine and Biological Chemistry, director of the Division of Pulmonary and Critical Care Medicine, and vice dean for research.

Since becoming vice dean for research in September 2011, Landon has demonstrated an exceptional ability to work closely with leaders throughout the university to advance all aspects of basic and translational research at the School of Medicine.

Ours is an enormous enterprise. The School of Medicine has been among the largest recipients of NIH biomedical funding for years, receiving $436 million in 2012. Landon has facilitated collaborative research by working with colleagues to assess core resources and research infrastructure while also overseeing research administration, policy coordination, and the identification and coordination of technology transfer opportunities. 

Landon’s ability to serve superbly in these multiple roles makes him the ideal person to undertake this new position as executive vice dean.

As executive vice dean, Landon will assist me in overseeing operations and program development in the School of Medicine.

Landon received his medical degree in 1989 from Vanderbilt University and first came to Hopkins that year as an intern in the Osler medical service. As a postdoctoral fellow and later, after joining the faculty as an assistant professor in 1997, he undertook important studies of water channels in the lung with 2003 Nobel Laureate Peter Agre. In 2005, he was selected to be the Director of the Division of Pulmonary and Critical Care Medicine.  
Landon was elected to the American Society for Clinical Investigation in 2006 for work on aquaporin water channels. His work currently focuses on mechanisms regulating repair of lung injury.

Landon’s outstanding qualities as a scientist and administrative leader, evidenced by his past and current accomplishments, are certain to prove immensely valuable in his new role as executive vice dean.

Sincerely,
Paul Rothman, M.D.
Dean of the Medical Faculty
CEO of Johns Hopkins Medicine